Titan Medical Inc (TMDIF)

[Frankestin]

On July 15, 2020, the Registrant’s board of directors adopted amendments to the Stock Option Plan (i) to allow for the grant of options to employees of the Company’s wholly-owned U.S. subsidiary, Titan Medical USA Inc., (ii) to provide that the exercise price of each stock option granted under the Stock Option Plan may not be lower than the greater of: (x) the volume weighted average price of the Common Shares on the Exchange (as defined in the Stock Option Plan) over the period of five days immediately preceding the date of the grant and (y) the closing price of the Common Shares on the Exchange on the last trading day preceding the date of grant, and (iii) to provide that stock options granted under the Stock Option Plan may be either incentive stock options qualified under Section 422 of the United States Internal Revenue Code or nonqualified stock options.

if the share price has been $ 2 what would have changed?